DE69614377D1 - Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum - Google Patents

Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum

Info

Publication number
DE69614377D1
DE69614377D1 DE69614377T DE69614377T DE69614377D1 DE 69614377 D1 DE69614377 D1 DE 69614377D1 DE 69614377 T DE69614377 T DE 69614377T DE 69614377 T DE69614377 T DE 69614377T DE 69614377 D1 DE69614377 D1 DE 69614377D1
Authority
DE
Germany
Prior art keywords
growth factor
epidermal growth
egf
gut
stomach
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69614377T
Other languages
English (en)
Other versions
DE69614377T2 (de
Inventor
Andre G Buret
D Grant Gall
James A Hardin
Merle E Olson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Technologies International Inc
Original Assignee
University Technologies International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Technologies International Inc filed Critical University Technologies International Inc
Publication of DE69614377D1 publication Critical patent/DE69614377D1/de
Application granted granted Critical
Publication of DE69614377T2 publication Critical patent/DE69614377T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69614377T 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum Expired - Fee Related DE69614377T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/438,901 US5753622A (en) 1995-05-10 1995-05-10 Use of epidermal growth factor as a gastrointestinal therapeutic agent
PCT/CA1996/000291 WO1996035445A1 (en) 1995-05-10 1996-05-09 The use of epidermal growth factor as a gastrointestinal therapeutic agent

Publications (2)

Publication Number Publication Date
DE69614377D1 true DE69614377D1 (de) 2001-09-13
DE69614377T2 DE69614377T2 (de) 2002-05-23

Family

ID=23742496

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69637002T Expired - Fee Related DE69637002T2 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen Wachstumsfaktors zur Steigerung der Gewichtszunahme beim Tier
DE69633583T Expired - Fee Related DE69633583T2 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen Wachstumsfaktors als Magen-Darm Therapeutikum
DE69614377T Expired - Fee Related DE69614377T2 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE69637002T Expired - Fee Related DE69637002T2 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen Wachstumsfaktors zur Steigerung der Gewichtszunahme beim Tier
DE69633583T Expired - Fee Related DE69633583T2 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen Wachstumsfaktors als Magen-Darm Therapeutikum

Country Status (13)

Country Link
US (2) US5753622A (de)
EP (3) EP1479394B1 (de)
JP (1) JP3549541B2 (de)
AT (3) ATE357927T1 (de)
AU (1) AU704675B2 (de)
CA (2) CA2220434C (de)
DE (3) DE69637002T2 (de)
DK (3) DK1479394T3 (de)
ES (2) ES2226681T3 (de)
HK (1) HK1072894A1 (de)
NZ (2) NZ501482A (de)
PT (1) PT1479394E (de)
WO (1) WO1996035445A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent
US5929051A (en) * 1998-05-13 1999-07-27 Carrington Laboratories, Inc. Aloe pectins
US6313103B1 (en) 1998-05-13 2001-11-06 Carrington Laboratories, Inc. Pectic substance as a growth factor stabilizer
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US20060014684A1 (en) * 2000-03-03 2006-01-19 University Technologies International Inc. Novel uses of EGF
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
CN1527879A (zh) * 2001-05-18 2004-09-08 加拿大农业及农业食品部 牛表皮生长因子的核酸序列和蛋白质序列
WO2003035102A1 (en) * 2001-10-26 2003-05-01 University Technologies International, Inc. Use of egf to inhibit pathogenic infections of the urogenital tract
CA2427190A1 (en) * 2002-04-30 2003-10-30 Alberta Research Council Inc. Production of recombinant epidermal growth factor in plants
AU2003250250B2 (en) 2002-06-19 2008-02-14 Intrexon Actobiotics Nv Methods and means to promote gut absorption
US20110245171A1 (en) * 2004-09-30 2011-10-06 Hardin James A Rehydration compositions comprising epidermal growth factor (egf)
US8703769B2 (en) * 2005-07-15 2014-04-22 The University Of North Carolina At Chapel Hill Use of EGFR inhibitors to prevent or treat obesity
US8748126B2 (en) 2005-11-29 2014-06-10 Actogenix N.V. Induction of mucosal tolerance to antigens
BRPI0807857A2 (pt) 2007-01-25 2014-05-27 Actogenix Nv Tratamento de doença imune por meio de distribuição através da mucosa de antígenos.
US20110275566A1 (en) * 2008-10-10 2011-11-10 Nationwide Children's Hospital Inc. Methods of treating necrotizing enterocolitis using heparin binding epidermal growth factor (hb-egf)
CN102696887B (zh) * 2012-06-20 2013-07-31 湖南海谷生物技术有限公司 一种具有营养保健促生长功能的饲料活性蛋粉及其生产方法
US11241480B2 (en) * 2017-01-26 2022-02-08 Washington University Methods for modulation of dietary and microbial exposure with compositions comprising an EGFR ligand
CN113813369B (zh) * 2021-11-09 2023-09-22 浙江省农业科学院 用于预防/治疗仔猪肠道损伤的egf/mmt复合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8409960D0 (en) * 1984-04-17 1984-05-31 Searle & Co Therapeutic method
ATE80307T1 (de) * 1986-12-11 1992-09-15 British Tech Group Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf.
EP0577903B1 (de) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Lactobacillus Acidophilus enthaltende Antigastritis-Mittel
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent

Also Published As

Publication number Publication date
DK1479394T3 (da) 2007-06-11
HK1072894A1 (en) 2005-09-16
DE69637002D1 (de) 2007-05-10
ATE357927T1 (de) 2007-04-15
US6656907B1 (en) 2003-12-02
JPH11505528A (ja) 1999-05-21
DK0824357T3 (da) 2001-10-08
EP1479394B1 (de) 2007-03-28
ATE203912T1 (de) 2001-08-15
DE69614377T2 (de) 2002-05-23
EP1092437B1 (de) 2004-10-06
CA2492724C (en) 2010-08-03
EP0824357B1 (de) 2001-08-08
ES2226681T3 (es) 2005-04-01
AU5641196A (en) 1996-11-29
DE69633583D1 (de) 2004-11-11
ATE278415T1 (de) 2004-10-15
EP0824357A1 (de) 1998-02-25
AU704675B2 (en) 1999-04-29
EP1479394A1 (de) 2004-11-24
JP3549541B2 (ja) 2004-08-04
DK1092437T3 (da) 2005-01-31
DE69637002T2 (de) 2007-08-16
CA2220434C (en) 2005-02-22
WO1996035445A1 (en) 1996-11-14
DE69633583T2 (de) 2006-02-23
CA2220434A1 (en) 1996-11-14
US5753622A (en) 1998-05-19
NZ307134A (en) 2000-02-28
EP1092437A1 (de) 2001-04-18
ES2285320T3 (es) 2007-11-16
NZ501482A (en) 2004-12-24
PT1479394E (pt) 2007-04-30
CA2492724A1 (en) 1996-11-14

Similar Documents

Publication Publication Date Title
HK1072894A1 (en) The use of epidermal growth factor (egf) for increasing weight gain in an animal
GR3006124T3 (de)
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE301937T1 (de) Verfahren zur herstellung eines produkts zur erhöhung der immunantwort bei haustieren mit verwendung einer kombination von antioxidantien
ATE95060T1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
EP0281809A3 (en) Sustained release compositions for parenteral administration and their use
DE59712094D1 (de) Mittel zur herstellung von aquarien- und gartenteichwasser und verwendung davon
DE69130497T2 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE3681144D1 (de) Verwendung biologisch aktiver copolymere zur herstellung eines arzneimittels zur stimulierung des wachstums von tieren.
ATE128865T1 (de) Verwendung von l-deprenyl zur herstellung eines arzneimittels zur behandlung der cushing's- krankheit.
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
ATE47274T1 (de) Tierstreu sowie verfahren zur herstellung derselben.
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
ATE8049T1 (de) 1,3-dioxan-5-yl-alkyltriazole, ihre herstellung, ihre verwendung zur regulierung des pflanzenwachstums und mittel dafuer.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
JPS5729270A (en) Preparation of nonheat-coagulable egg white
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
Potapchenko et al. Dosage-time dependency of effect of silver in water on pathogenic escherichia
Royston Formation, function and potential relevance in anaesthesia.
EP0192222A3 (en) Agent for preventing, decreasing or retarding the protein decomposition in the human or animal digestive tract, and process for its production
MD512C2 (ro) Inhibitor dezvoltării mugurilor la altoaiele viţei de vie
UA13697A1 (uk) Спосіб передпосівhої обробки hасіhhя

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee